Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.21 USD | +3.55% | +6.64% | +13.03% |
14/02 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
14/02 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.03% | 17.87M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.08% | 239B | |
+8.00% | 204B | |
-7.61% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Aytu BioPharma Gets FDA Approval to Transfer Production of Cotempla to Third Party